Guy Griggs is jumping from one news giant to another. Griggs, currently vice president of national sales for New York Times Co., will join Warner Bros. Discovery ‘s CNN later this month as its ...

The REINS Act is superior because it reverses this dynamic by requiring congressional approval for all major regulations — an opt-in system, so to speak, instead of opt-out.

For our first feature, we took a trip out to Healing Reins -- where lives are transformed through the power of horse therapy. A horse enjoying time in a pasture at Healing Reins Hazel Quinn is an ...

Thus far in 2025, lawmakers in Kentucky, Wyoming, Utah, and Oklahoma have enacted REINS Act legislation. At least three more state legislatures are likely to pass a REINS Act this summer.

Hiring platform Indeed’s CEO Chris Hyams (pictured above) said on Monday that he is stepping down from the role. The CEO of the company’s parent firm Recruit, Hisayuki Idekoba, will return to ...

The Trump administration reportedly tightens the reins on Veterans Affairs scientists VA officials want contributions to medical journals to go through them after two agency doctors highlighted ...

Sterling Black, CEO of Minnesota-based LS Black Constructors, is passing the leadership reins to new president Mark Liska, the company said in a press release. Liska takes on his new role ...

Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and ...

Online gambling is engineered addiction — here’s how to rein it in By Isaac Rose-Berman Published May 25, 2025, 10:10 a.m. ET ...

Michael Penix Jr. has all the tools needed to take the reins as QB1 in Atlanta Josh Petry May 23, 2025 10:44 AM EDT In this story: ...

The deregulatory language, based on the “Regulations from the Executive In Need of Scrutiny (REINS) Act,” would have upended federal agencies’ independent rulemaking powers. Advertisement ...

Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and ...